– QINLOCK is the First Approved Tyrosine Kinase Inhibitor Designed Specifically for GIST Regardless of Patients’ Mutational Status – – QINLOCK Approved...
Solid performance in context of COVID-19 market challenges Healthy longer-term commercial momentum with large, signature project wins Company to report second quarter...
NEW DELHI, India–(BUSINESS WIRE)–#ahmadkhawaja—Khawaja Holdings, a multinational holding company, announces new plans to expand into the United States. Khawaja Holdings, led by...
DUBLIN–(BUSINESS WIRE)–The “Malaysia Telecom Operators Country Intelligence 2020” report has been added to ResearchAndMarkets.com’s offering. Malaysia Telecom Operators Country Intelligence Report provides...
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to...
Inzomelid is a potent, selective, orally-available, brain-penetrant NLRP3 inflammasome inhibitor intended for treatment of debilitating inflammatory diseases Inflazome announced positive Phase Ib...
HONG KONG–(BUSINESS WIRE)–MetLife’s 360Health has outshined several insurers and non-insurers to win the Gold Stevie® Award for Innovation in Heath & Wellness...
WarpDrive to Refer Customers Seeking Next-Generation Cloud ERP SAN RAMON, Calif.–(BUSINESS WIRE)–#CloudERP—Rootstock Software – a leading provider of cloud Enterprise Resource Planning...
Combines 6mm-by-10mm size and world-leading 43% power efficiency TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today they have developed a new technology...
Finalist companies to compete in $300,000 Grand Finals at the MedTech Forum LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator, the premier nonprofit accelerator...